Sylvie Ryckebusch is a seasoned pharmaceutical executive with over twenty years of experience in business development, alliance management, and corporate strategy. She is current Chief Business Officer of BioInvent International, and is a founder of Octave Biotech S.A. based in Geneva, Switzerland, which assists numerous life sciences companies with business development strategy and implementation. Sylvie is a Board Member of Domain Therapeutics as well as an Adjunct Professor at the Grenoble School of Management. Sylvie has served in key positions at Serono, Merck KGaA and has been instrumental in establishing numerous product and technology transactions as well as several startup creations.
Sylvie earned a PhD in neurobiology at the California Institute of Technology before completing a postdoctoral fellowship at the Harvard Business School. She went on to spend four years with McKinsey & Company before joining the pharmaceutical industry.